Background
Infection, Cancer
INFECTIOUS DISEASES, ALLERGY, INFECTION, CANCER
Edited by: Javeed Ahmad, National Institute of Allergy and Infectious Diseases (NIH), United StatesReviewed by: Sonam Raj, National Cancer Institute (NIH), United States; Abir Kumar Panda, National Institute of Allergy and Infectious Diseases (NIH), United States†These authors share senior authorshipThis article was submitted to Virus and Host, a section of the journal Frontiers in Cellular and Infection MicrobiologyThe main objective was to evaluate the efficacy of intranasal photodynamic therapy (PDT) in SARS-CoV-2 mildly symptomatic carriers on decreasing the infectivity period. SARS-CoV-2-specific immune-stimulating effects and safety were also analysed.